Back to Journals » Cancer Management and Research » Volume 13

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression

Total article views   HTML views PDF downloads Totals
5,749 Dovepress* 5,288+ 639 5,927
PubMed Central* 461 183 644
Totals 5,749 822 6,571
*Since 18 May 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar